Spectral AI Adds Additional Clinical Sites To Multi-Center Diabetic Foot Ulcer Study
Portfolio Pulse from Benzinga Newsdesk
Spectral AI, Inc. (NASDAQ:MDAI) has announced the addition of seven clinical sites to support the development of its diabetic foot ulcer (DFU) application for the DeepView® Wound Imaging System. The technology combines multi-spectral imaging and AI to provide immediate healing assessments of DFUs. The data collected from these sites will be used to develop the DFU healing prediction algorithm and support applications for FDA, UKCA, and CE mark approval for DeepView®'s DFU indication.
October 16, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Spectral AI's addition of seven clinical sites for the development of its DFU application for the DeepView® Wound Imaging System could potentially enhance the company's product offering and increase its chances of gaining regulatory approval.
The addition of seven clinical sites will provide more data for the development of Spectral AI's DFU healing prediction algorithm. This could potentially enhance the company's product offering and increase its chances of gaining regulatory approval, which would likely have a positive impact on the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100